Detalles de la búsqueda
1.
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Br J Cancer
; 130(5): 777-787, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191609
2.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
BMC Cancer
; 21(1): 64, 2021 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33446148
3.
Clinical significance of baseline Pan-Immune-Inflammation Value and its dynamics in metastatic colorectal cancer patients under first-line chemotherapy.
Sci Rep
; 12(1): 6893, 2022 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35477740
4.
Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA.
Clin Epigenetics
; 14(1): 86, 2022 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810318
5.
Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data.
Sci Rep
; 11(1): 14321, 2021 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253805
6.
Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method.
Healthcare (Basel)
; 9(6)2021 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34205026
7.
Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature.
Lung Cancer
; 108: 217-221, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28625638
Resultados
1 -
7
de 7
1
Próxima >
>>